Value Aligned Research Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$363M Buy
2,640,800
+541,300
+26% +$76.4M 0.74% 32
2026
Q2
$308M Sell
2,099,500
-175,200
-8% -$31.8M 0.77% 31
2026
Q1
$335M Buy
2,274,700
+1,756,600
+339% +$286M 1.62% 15
2025
Q4
$101M Buy
518,100
+168,100
+48% +$40M 1.02% 31
2025
Q3
$98.4M Buy
350,000
+53,700
+18% +$13.7M 1.2% 25
2025
Q2
$64.8M Buy
296,300
+257,200
+658% +$41.5M 1.37% 19
2025
Q1
$5.47M Buy
+39,100
New +$6.37M 0.4% 30

Other funds holding ORCL

Value Aligned Research Advisors's ORCL Position: Q3 2026 in Review

Value Aligned Research Advisors reduced its Oracle (ORCL) stake by 33% in Q3 2026, selling an estimated $5.4M and leaving 76,826 shares worth $10.5M. The position accounts for 0.02% of the portfolio, ranked #148.

Value Aligned Research Advisors first reported a position in ORCL in Q1 2025 and has held it in 5 quarters since. The position peaked at $27.6M in Q4 2025. 3,456 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • Value Aligned Research Advisors held 76,826 shares of Oracle worth $10.5M as of Q3 2026.
  • Value Aligned Research Advisors sold 38,252 Oracle shares in Q3 2026, an estimated $5.4M.
  • Oracle made up 0.02% of Value Aligned Research Advisors's portfolio in Q3 2026, its #148 holding.
  • Value Aligned Research Advisors first reported a position in Oracle in Q1 2025 and has held it in 5 quarters since.
  • Value Aligned Research Advisors's Oracle position peaked at $27.6M in Q4 2025.
  • 3,456 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on Value Aligned Research Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.